Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-056733
Filing Date
2021-09-17
Accepted
2021-09-17 19:04:08
Documents
1
Period of Report
2021-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12083
  Complete submission text file 0001209191-21-056733.txt   13515
Mailing Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451 9787296480
Morphic Holding, Inc. (Issuer) CIK: 0001679363 (see all company filings)

EIN.: 473878772 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MORPHIC HOLDING, INC. 35 GATEHOUSE DRIVE A2 WALTHAM ME 02451
Business Address
Linde Peter (Reporting) CIK: 0001805908 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38940 | Film No.: 211261709